About: MediGene     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:SocialGroup107950920, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FMediGene&graph=http%3A%2F%2Fdbpedia.org&graph=http%3A%2F%2Fdbpedia.org

Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development.

AttributesValues
rdf:type
rdfs:label
  • Medigene (de)
  • MediGene (en)
rdfs:comment
  • Die Medigene AG ist ein an der Frankfurter Wertpapierbörse notiertes Biotechnologie-Unternehmen mit Hauptsitz in Martinsried bei München. Das Unternehmen entwickelt Immuntherapien zur Steigerung der T-Zell-Aktivität gegen solide Krebserkrankungen. Erste Produktkandidaten befinden sich in der klinischen Entwicklung. Die Aktien der Medigene sind im Prime Standard der Deutschen Börse notiert. (de)
  • Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. (en)
foaf:name
  • Medigene AG (en)
foaf:homepage
name
  • Medigene AG (en)
location
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
foundation
homepage
industry
key people
  • Prof Dolores J Schendel , Gerd Zettlmeissl (en)
location
traded as
  • MDG1 (en)
type
  • Stock company (en)
has abstract
  • Die Medigene AG ist ein an der Frankfurter Wertpapierbörse notiertes Biotechnologie-Unternehmen mit Hauptsitz in Martinsried bei München. Das Unternehmen entwickelt Immuntherapien zur Steigerung der T-Zell-Aktivität gegen solide Krebserkrankungen. Erste Produktkandidaten befinden sich in der klinischen Entwicklung. Die Aktien der Medigene sind im Prime Standard der Deutschen Börse notiert. (de)
  • Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. (en)
prov:wasDerivedFrom
page length (characters) of wiki page
founding year
industry
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (61 GB total memory, 51 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software